Influence of age on venodilator effect of isoproterenol and amrinone

European Journal of Clinical Pharmacology

Volumn 50, Issue 1-2, 1996, Pages 37-40

  Harada, K ^a   Ohashi, K ^b   Kumagai, Y ^a   Ohmori, M ^a   Fujimura, A ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related change; Amrinone; Dorsal hand vein technique; Elderly; venodilation; Isoproterenol

Indexed keywords

AMRINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; VASODILATOR AGENT; CYCLIC AMP; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; SYNESIN; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; HAND; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION; VEIN; AGE; BLOOD VESSEL DIAMETER; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; VEIN DILATATION; VOLUNTEER;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; AGING; AMRINONE; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HAND; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; PULSE; REGIONAL BLOOD FLOW; VASODILATOR AGENTS; VEINS;

EID: 0029666054     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050066     Document Type: Article

References (12)

1. Somlyo AP, Somlyo AV, Smiesko V (1972) Cyclic AMP and vascular smooth muscle. In: Greengard P, Robinson GA (eds) Advances in cyclic nucleotide research. Raven Press, New York, pp 175-193
2. van Brummelen P, Buhler FR, Kiowaski W, Amann FW (1981) Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci 60:571-577
3. Pan HYM, Hoffman BB, Pershe RA, Blaschke TF (1986) Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol exp Ther 239: 802-807
4. Benolli JR, Grossman W, Braunwald E, Davolos DD, Alousi AA (1978) Hemodynamic assessement of amrinone: a new inotropic agent. N Engl J Med 299:1373-1377
5. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB (1986) Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem Pharmacol 35:787-800
6. Pall JS, Linda TH, Mark HP, Ross GB, Cynthia RB, Dale BE (1988) Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol 150:85-94
7. Millard RW, Duke G, Grupp G, Grupp I, Alousl A, Schwartz A (1980) Direct vasodilator and positive inotropic action of amrinone. J Mol Cell Cardiol 12:647-652
8. Firth BG, Ratner AV, Grassman ED, Winniford MD, Nicod P, Hillis LD (1984) Assesment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Am J Cardiol 54:1331-1336
9. Aellig WH (1981) A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 11:237-243
10. Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ (1981) Alternations in leukocyte β-receptor affinity with aging. N Engl J Med 310:815-819
11. Taormina-Paplanus LM, Strebel CA, Michaelson CR (1983) Drug therapy for congestive heart failure. In: Michaelson CR, St. Louis (eds) Congestive Heart Failure Mosby, pp 273-274
12. Rich MW, Woods WL, Davila-Roman VG, Morello PJ, Kurg H, Barbavash R (1995) A Randomized Comparison of Intravenous Amrinone Versus Dobutamine in Older Patients wih Decompensated Congestive Heart Failure. J Am Geriatr Soc 43:271-274